These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
439 related items for PubMed ID: 32056068
1. Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies. Asakawa K, Yoshizawa K, Aoki A, Kimura Y, Tanaka T, Ohashi K, Hayashi M, Kikuchi T, Sato S, Takada T. Clin Rheumatol; 2020 Jul; 39(7):2171-2178. PubMed ID: 32056068 [Abstract] [Full Text] [Related]
2. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease. Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, Enomoto N, Inui N, Nakamura Y, Hosono Y, Imura Y, Mimori T, Suda T. Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997 [Abstract] [Full Text] [Related]
3. Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody. Kishaba T, McGill R, Nei Y, Ibuki S, Momose M, Nishiyama K, Nagano H, Yamashiro S. J Med Invest; 2018 Dec; 65(3.4):251-257. PubMed ID: 30282869 [Abstract] [Full Text] [Related]
9. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease. Fujisawa T, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T. J Rheumatol; 2019 Aug; 46(8):935-942. PubMed ID: 31092718 [Abstract] [Full Text] [Related]
10. The comparison of nailfold videocapillaroscopy findings between anti-melanoma differentiation-associated gene 5 antibody and anti-aminoacyl tRNA synthetase antibody in patients with dermatomyositis complicated by interstitial lung disease. Wakura R, Matsuda S, Kotani T, Shoda T, Takeuchi T. Sci Rep; 2020 Sep 24; 10(1):15692. PubMed ID: 32973255 [Abstract] [Full Text] [Related]
11. Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease. Kaieda S, Gono T, Masui K, Nishina N, Sato S, Kuwana M, A Multicenter Retrospective Cohort of Japanese Patients with Myositis-associated ILD (JAMI) investigators. PLoS One; 2020 Sep 24; 15(6):e0234523. PubMed ID: 32525903 [Abstract] [Full Text] [Related]
12. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis. Hozumi H, Fujisawa T, Nakashima R, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Inui N, Nakamura Y, Mimori T, Suda T. J Rheumatol; 2019 May 24; 46(5):509-517. PubMed ID: 30647164 [Abstract] [Full Text] [Related]
16. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study. Hozumi H, Enomoto N, Kono M, Fujisawa T, Inui N, Nakamura Y, Sumikawa H, Johkoh T, Nakashima R, Imura Y, Mimori T, Suda T. PLoS One; 2015 May 24; 10(3):e0120313. PubMed ID: 25789468 [Abstract] [Full Text] [Related]
18. Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia--with or without PM/DM. Takato H, Waseda Y, Watanabe S, Inuzuka K, Katayama N, Ichikawa Y, Yasui M, Fujimura M. Respir Med; 2013 Jan 24; 107(1):128-33. PubMed ID: 23137883 [Abstract] [Full Text] [Related]
19. Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis. Matsushita T, Hasegawa M, Fujimoto M, Hamaguchi Y, Komura K, Hirano T, Horikawa M, Kondo M, Orito H, Kaji K, Saito Y, Matsushita Y, Kawara S, Yasui M, Seishima M, Ozaki S, Kuwana M, Ogawa F, Sato S, Takehara K. J Rheumatol; 2007 May 24; 34(5):1012-8. PubMed ID: 17309126 [Abstract] [Full Text] [Related]